Form 8-K - Current report:
SEC Accession No. 0001562762-24-000025
Filing Date
2024-02-15
Accepted
2024-02-15 16:15:34
Documents
14
Period of Report
2024-02-09
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K 20240209.htm   iXBRL 8-K 25053
  Complete submission text file 0001562762-24-000025.txt   142856

Data Files

Seq Description Document Type Size
2 EX-101.SCH vaxx-20230922.xsd EX-101.SCH 1934
3 EX-101.LAB vaxx-20230922_lab.xml EX-101.LAB 15603
4 EX-101.PRE vaxx-20230922_pre.xml EX-101.PRE 11205
16 EXTRACTED XBRL INSTANCE DOCUMENT 20240209_htm.xml XML 4170
Mailing Address 505 ODYSSEY WAY EXPLORATION PARK FL 32953
Business Address 505 ODYSSEY WAY EXPLORATION PARK FL 32953 (254) 244-5739
Vaxxinity, Inc. (Filer) CIK: 0001851657 (see all company filings)

EIN.: 862083865 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41058 | Film No.: 24643999
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)